Company patents
Relign Corporation
Relign Corporation's patent strategy is almost entirely concentrated in Medical Diagnostics & Surgery, representing 100.0% of its portfolio. Surprisingly, despite this singular focus, patenting in this core area has seen a significant decline, with a -31.2% YoY drop in 2025 and a further -90.9% decline so far in 2026, suggesting a potential shift away from active innovation in its primary domain.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
46 US filings (since 2023) · 3 categories · 3 themes
Focuses on the mechanical design, articulation, and actuation of hand-held or robotic surgical instruments, including improvements in stapling, cutting, grasping, and tissue manipulation.
Design and application of devices that are inserted into the body or implanted to treat diseases, modulate physiological functions, or repair anatomical structures.
Systems and methods that use imaging technologies, computer vision, and augmented reality to provide real-time guidance, localization, and visualization during surgical procedures or for detailed anatomical assessment.
Patents
Showing 1-10 of 82